The University of Chicago Header Logo

Connection

George Perry to Humans

Back to Details
This is a "connection" page, showing publications George Perry has written about Humans.
George Perry
Connection Strength
1.949
Humans
  1. Genomic signatures of adaptation in native lizards exposed to human-introduced fire ants. Nat Commun. 2025 01 02; 16(1):89.
    View in: PubMed
    Score: 0.029
  2. Central role of brain regulatory T cells in the inflammatory cascade in Alzheimer's disease. Proc Natl Acad Sci U S A. 2024 Aug 06; 121(32):e2412255121.
    View in: PubMed
    Score: 0.028
  3. Stem Cell Interventions in Neurology: From Bench to Bedside. J Alzheimers Dis. 2024; 101(s1):S395-S416.
    View in: PubMed
    Score: 0.027
  4. Oxidative Stress in Alzheimer's Disease: The Shortcomings of Antioxidant Therapies. J Alzheimers Dis. 2024; 101(s1):S155-S178.
    View in: PubMed
    Score: 0.027
  5. Analysis of Alzheimer's Disease-Related Mortality Rates Among the Elderly Populations Across the United States: An Analysis of Demographic and Regional Disparities from 1999 to 2020. Curr Alzheimer Res. 2024; 21(6):384-394.
    View in: PubMed
    Score: 0.027
  6. Exploring Molecular Targets for Mitochondrial Therapies in Neurodegenerative Diseases. Int J Mol Sci. 2023 Aug 06; 24(15).
    View in: PubMed
    Score: 0.026
  7. The retina-brain axis and diabetic retinopathy. Eur J Ophthalmol. 2023 Nov; 33(6):2079-2095.
    View in: PubMed
    Score: 0.026
  8. Alzheimer's Disease: Not Just for the Aged? J Alzheimers Dis. 2023; 91(3):923-924.
    View in: PubMed
    Score: 0.025
  9. Lessons from antiamyloid-ß immunotherapies in Alzheimer's disease. Handb Clin Neurol. 2023; 193:267-292.
    View in: PubMed
    Score: 0.025
  10. Playing Russian Roulette with Alzheimer's Disease Patients: Do the Cognitive Benefits of Lecanemab Outweigh the Risk of Edema, Stroke and Encephalitis? J Alzheimers Dis. 2023; 92(3):799-801.
    View in: PubMed
    Score: 0.025
  11. Neuropathologic Changes Provide Insights into Key Mechanisms of Alzheimer Disease and Related Dementia. Am J Pathol. 2022 10; 192(10):1340-1346.
    View in: PubMed
    Score: 0.025
  12. An integrative skeletal and paleogenomic analysis of stature variation suggests relatively reduced health for early European farmers. Proc Natl Acad Sci U S A. 2022 04 12; 119(15):e2106743119.
    View in: PubMed
    Score: 0.024
  13. SWADESH: A Comprehensive Platform for Multimodal Data and Analytics for Advanced Research in Alzheimer's Disease and Other Brain Disorders. J Alzheimers Dis. 2022; 85(1):1-5.
    View in: PubMed
    Score: 0.024
  14. Evolutionary medicine. Elife. 2021 07 22; 10.
    View in: PubMed
    Score: 0.023
  15. Patterns of recent natural selection on genetic loci associated with sexually differentiated human body size and shape phenotypes. PLoS Genet. 2021 06; 17(6):e1009562.
    View in: PubMed
    Score: 0.023
  16. Scanning the human genome for "signatures" of positive selection: Transformative opportunities and ethical obligations. Evol Anthropol. 2021 Mar; 30(2):113-121.
    View in: PubMed
    Score: 0.022
  17. Modern, archaeological, and paleontological DNA analysis of a human-harvested marine gastropod (Strombus pugilis) from Caribbean Panama. Mol Ecol Resour. 2021 Jul; 21(5):1517-1528.
    View in: PubMed
    Score: 0.022
  18. Status and future directions of clinical trials in Alzheimer's disease. Int Rev Neurobiol. 2020; 154:3-50.
    View in: PubMed
    Score: 0.021
  19. Preventive and Therapeutic Strategies in Alzheimer's Disease: Focus on Oxidative Stress, Redox Metals, and Ferroptosis. Antioxid Redox Signal. 2021 03 10; 34(8):591-610.
    View in: PubMed
    Score: 0.021
  20. How human behavior can impact the evolution of genetically-mediated behavior in wild non-human species. J Comp Physiol A Neuroethol Sens Neural Behav Physiol. 2020 05; 206(3):337-342.
    View in: PubMed
    Score: 0.021
  21. Studying human and nonhuman primate evolutionary biology with powerful in vitro and in vivo functional genomics tools. Evol Anthropol. 2020 May; 29(3):143-158.
    View in: PubMed
    Score: 0.021
  22. Neuroprotective and Antioxidant Effect of Ginkgo biloba Extract Against AD and Other Neurological Disorders. Neurotherapeutics. 2019 07; 16(3):666-674.
    View in: PubMed
    Score: 0.020
  23. Horse Paleogenomes and Human-Animal Interactions in Prehistory. Trends Genet. 2019 07; 35(7):473-475.
    View in: PubMed
    Score: 0.020
  24. The amyloid cascade and Alzheimer's disease therapeutics: theory versus observation. Lab Invest. 2019 07; 99(7):958-970.
    View in: PubMed
    Score: 0.019
  25. Single-channel permeability and glycerol affinity of human aquaglyceroporin AQP3. Biochim Biophys Acta Biomembr. 2019 04 01; 1861(4):768-775.
    View in: PubMed
    Score: 0.019
  26. Tau Biology, Tauopathy, Traumatic Brain Injury, and Diagnostic Challenges. J Alzheimers Dis. 2019; 67(2):447-467.
    View in: PubMed
    Score: 0.019
  27. Analysis of post-translational modifications in Alzheimer's disease by mass spectrometry. Biochim Biophys Acta Mol Basis Dis. 2019 08 01; 1865(8):2040-2047.
    View in: PubMed
    Score: 0.019
  28. Gibbs Free-Energy Gradient along the Path of Glucose Transport through Human Glucose Transporter 3. ACS Chem Neurosci. 2018 11 21; 9(11):2815-2823.
    View in: PubMed
    Score: 0.019
  29. Towards an Integrative Understanding of tRNA Aminoacylation-Diet-Host-Gut Microbiome Interactions in Neurodegeneration. Nutrients. 2018 Mar 26; 10(4).
    View in: PubMed
    Score: 0.018
  30. Iron·ic facts about dementia. J Neurol Neurosurg Psychiatry. 2018 05; 89(5):446-447.
    View in: PubMed
    Score: 0.018
  31. Expression Profiling of Cytokine, Cholinergic Markers, and Amyloid-ß Deposition in the APPSWE/PS1dE9 Mouse Model of Alzheimer's Disease Pathology. J Alzheimers Dis. 2018; 62(1):467-476.
    View in: PubMed
    Score: 0.018
  32. Thermodynamics of Amyloid-ß Fibril Elongation: Atomistic Details of the Transition State. ACS Chem Neurosci. 2018 04 18; 9(4):783-789.
    View in: PubMed
    Score: 0.018
  33. Monkeys overharvest shellfish. Elife. 2017 09 13; 6.
    View in: PubMed
    Score: 0.018
  34. Harnessing ancient genomes to study the history of human adaptation. Nat Rev Genet. 2017 11; 18(11):659-674.
    View in: PubMed
    Score: 0.018
  35. A massively parallel strategy for STR marker development, capture, and genotyping. Nucleic Acids Res. 2017 Sep 06; 45(15):e142.
    View in: PubMed
    Score: 0.018
  36. Consequences of RNA oxidation on protein synthesis rate and fidelity: implications for the pathophysiology of neuropsychiatric disorders. Biochem Soc Trans. 2017 Oct 15; 45(5):1053-1066.
    View in: PubMed
    Score: 0.017
  37. Advances in Alzheimer's Diagnosis and Therapy: The Implications of Nanotechnology. Trends Biotechnol. 2017 10; 35(10):937-953.
    View in: PubMed
    Score: 0.017
  38. Extending Genome-Wide Association Study Results to Test Classic Anthropological Hypotheses: Human Third Molar Agenesis and the "Probable Mutation Effect". Hum Biol. 2017 04; 89(2):157-169.
    View in: PubMed
    Score: 0.017
  39. Archaeogenomic evidence reveals prehistoric matrilineal dynasty. Nat Commun. 2017 02 21; 8:14115.
    View in: PubMed
    Score: 0.017
  40. Modulation of Parkinson's Disease Associated Protein Rescues Alzheimer's Disease Degeneration. J Alzheimers Dis. 2017; 55(1):73-75.
    View in: PubMed
    Score: 0.017
  41. Dementia Pugilistica Revisited. J Alzheimers Dis. 2017; 60(4):1209-1221.
    View in: PubMed
    Score: 0.017
  42. Hunter-gatherer genomics: evolutionary insights and ethical considerations. Curr Opin Genet Dev. 2016 Dec; 41:1-7.
    View in: PubMed
    Score: 0.016
  43. Nucleic acid oxidative damage in Alzheimer's disease-explained by the hepcidin-ferroportin neuronal iron overload hypothesis? J Trace Elem Med Biol. 2016 Dec; 38:1-9.
    View in: PubMed
    Score: 0.016
  44. High-resolution analytical imaging and electron holography of magnetite particles in amyloid cores of Alzheimer's disease. Sci Rep. 2016 04 28; 6:24873.
    View in: PubMed
    Score: 0.016
  45. Overview of Alzheimer's Disease and Some Therapeutic Approaches Targeting Aß by Using Several Synthetic and Herbal Compounds. Oxid Med Cell Longev. 2016; 2016:7361613.
    View in: PubMed
    Score: 0.016
  46. Mexico City normal weight children exposed to high concentrations of ambient PM2.5 show high blood leptin and endothelin-1, vitamin D deficiency, and food reward hormone dysregulation versus low pollution controls. Relevance for obesity and Alzheimer disease. Environ Res. 2015 Jul; 140:579-92.
    View in: PubMed
    Score: 0.015
  47. Ancient DNA and human evolution. J Hum Evol. 2015 Feb; 79:1-3.
    View in: PubMed
    Score: 0.015
  48. Insights into hominin phenotypic and dietary evolution from ancient DNA sequence data. J Hum Evol. 2015 Feb; 79:55-63.
    View in: PubMed
    Score: 0.015
  49. Adaptive, convergent origins of the pygmy phenotype in African rainforest hunter-gatherers. Proc Natl Acad Sci U S A. 2014 09 02; 111(35):E3596-603.
    View in: PubMed
    Score: 0.014
  50. Parallels between major depressive disorder and Alzheimer's disease: role of oxidative stress and genetic vulnerability. Cell Mol Neurobiol. 2014 Oct; 34(7):925-49.
    View in: PubMed
    Score: 0.014
  51. Plaques and tangles: birthmarks of the aging soul. Preface. Biochem Pharmacol. 2014 Apr 15; 88(4):423-5.
    View in: PubMed
    Score: 0.014
  52. The complexities of the pathology-pathogenesis relationship in Alzheimer disease. Biochem Pharmacol. 2014 Apr 15; 88(4):671-6.
    View in: PubMed
    Score: 0.014
  53. Lester (Skip) Binder (1949-2013): in the beginning was tau. J Alzheimers Dis. 2014; 40 Suppl 1:S5.
    View in: PubMed
    Score: 0.014
  54. Apolipoprotein E4 prevents growth of malaria at the intraerythrocyte stage: implications for differences in racial susceptibility to Alzheimer's disease. J Health Care Poor Underserved. 2013 Nov; 24(4 Suppl):70-8.
    View in: PubMed
    Score: 0.013
  55. The largest unmet market: chronic diseases of aging. Mini Rev Med Chem. 2013 Jan; 13(1):1.
    View in: PubMed
    Score: 0.013
  56. Mitochondrial DNA oxidative damage and repair in aging and Alzheimer's disease. Antioxid Redox Signal. 2013 Jun 20; 18(18):2444-57.
    View in: PubMed
    Score: 0.013
  57. Pathogenesis and disease-modifying therapy in Alzheimer's disease: the flat line of progress. Arch Med Res. 2012 Nov; 43(8):694-8.
    View in: PubMed
    Score: 0.013
  58. Oxidative damage to RNA in aging and neurodegenerative disorders. Neurotox Res. 2012 Oct; 22(3):231-48.
    View in: PubMed
    Score: 0.012
  59. Evolutionary genetics of the human Rh blood group system. Hum Genet. 2012 Jul; 131(7):1205-16.
    View in: PubMed
    Score: 0.012
  60. Mark A. Smith: neurocytochemistry innovator. J Neurochem. 2012 Mar; 120(6):1139-40.
    View in: PubMed
    Score: 0.012
  61. Untangling the vascular web from Alzheimer disease and oxidative stress. Can J Neurol Sci. 2012 Jan; 39(1):4.
    View in: PubMed
    Score: 0.012
  62. Comparative RNA sequencing reveals substantial genetic variation in endangered primates. Genome Res. 2012 Apr; 22(4):602-10.
    View in: PubMed
    Score: 0.012
  63. A genome sequence resource for the aye-aye (Daubentonia madagascariensis), a nocturnal lemur from Madagascar. Genome Biol Evol. 2012; 4(2):126-35.
    View in: PubMed
    Score: 0.012
  64. Hydroxynonenal-generated crosslinking fluorophore accumulation in Alzheimer disease reveals a dichotomy of protein turnover. Free Radic Biol Med. 2012 Feb 01; 52(3):699-704.
    View in: PubMed
    Score: 0.012
  65. Antioxidant approaches for the treatment of Alzheimer's disease. Expert Rev Neurother. 2010 Jul; 10(7):1201-8.
    View in: PubMed
    Score: 0.011
  66. Molecular pathogenesis of Alzheimer's disease: reductionist versus expansionist approaches. Int J Mol Sci. 2009 Mar; 10(3):1386-1406.
    View in: PubMed
    Score: 0.010
  67. The evolutionary significance of copy number variation in the human genome. Cytogenet Genome Res. 2008; 123(1-4):283-7.
    View in: PubMed
    Score: 0.010
  68. RNA oxidation in Alzheimer disease and related neurodegenerative disorders. Acta Neuropathol. 2009 Jul; 118(1):151-66.
    View in: PubMed
    Score: 0.010
  69. Evolution of the human pygmy phenotype. Trends Ecol Evol. 2009 Apr; 24(4):218-25.
    View in: PubMed
    Score: 0.010
  70. Antioxidant therapy in Alzheimer's disease: theory and practice. Mini Rev Med Chem. 2008 Nov; 8(13):1395-406.
    View in: PubMed
    Score: 0.010
  71. Different selective pressures shape the molecular evolution of color vision in chimpanzee and human populations. Mol Biol Evol. 2008 Dec; 25(12):2735-43.
    View in: PubMed
    Score: 0.009
  72. Copy number variation and evolution in humans and chimpanzees. Genome Res. 2008 Nov; 18(11):1698-710.
    View in: PubMed
    Score: 0.009
  73. The fine-scale and complex architecture of human copy-number variation. Am J Hum Genet. 2008 Mar; 82(3):685-95.
    View in: PubMed
    Score: 0.009
  74. Diet and the evolution of human amylase gene copy number variation. Nat Genet. 2007 Oct; 39(10):1256-60.
    View in: PubMed
    Score: 0.009
  75. The evolutionary history of human and chimpanzee Y-chromosome gene loss. Mol Biol Evol. 2007 Mar; 24(3):853-9.
    View in: PubMed
    Score: 0.008
  76. Where does the neighborhood go? Trust, social engagement, and health among older adults in Baltimore City. Health Place. 2016 09; 41:58-66.
    View in: PubMed
    Score: 0.008
  77. Hotspots for copy number variation in chimpanzees and humans. Proc Natl Acad Sci U S A. 2006 May 23; 103(21):8006-11.
    View in: PubMed
    Score: 0.008
  78. Triangulating Syndemic Services and Drug Treatment Policy: Improving Drug Treatment Portal Locations in Baltimore City. Prog Community Health Partnersh. 2016; 10(2):319-27.
    View in: PubMed
    Score: 0.008
  79. Molecular evolution of the primate developmental genes MSX1 and PAX9. Mol Biol Evol. 2006 Mar; 23(3):644-54.
    View in: PubMed
    Score: 0.008
  80. Is US residence a risk factor for Alzheimer's disease? J Alzheimers Dis. 2025 Sep; 107(2):496-498.
    View in: PubMed
    Score: 0.008
  81. Reducing the threats of rodent-borne zoonoses requires an understanding and leveraging of three key pillars: disease ecology, synanthropy, and rodentation. Lancet Planet Health. 2025 Sep; 9(9):101300.
    View in: PubMed
    Score: 0.008
  82. Redox metals and oxidative abnormalities in human prion diseases. Acta Neuropathol. 2005 Sep; 110(3):232-8.
    View in: PubMed
    Score: 0.008
  83. Identifying patients with mild cognitive impairment at high risk of transitioning to Alzheimer's disease using routinely collected data. J Alzheimers Dis. 2025 Nov; 108(1_suppl):S334-S343.
    View in: PubMed
    Score: 0.008
  84. Oxidative stress and neurodegeneration. Ann N Y Acad Sci. 2005 Jun; 1043:545-52.
    View in: PubMed
    Score: 0.008
  85. Conventional and Emerging Drug Targeting Sites in Alzheimer's Disease and the Role of Translational Informatics in its Diagnosis and Management. Curr Neuropharmacol. 2025; 23(14):1894-1917.
    View in: PubMed
    Score: 0.007
  86. Exacerbated mitochondrial dynamic abnormalities without evident tau pathology in rapidly progressive Alzheimer's disease. J Alzheimers Dis. 2024 Dec; 102(4):1074-1083.
    View in: PubMed
    Score: 0.007
  87. The Amyloid Cascade Hypothesis: A Conclusion in Search of Support. Am J Pathol. 2025 Nov; 195(11):1988-1997.
    View in: PubMed
    Score: 0.007
  88. Exploring the rhodanine universe: Design and synthesis of fluorescent rhodanine-based derivatives as anti-fibrillar and anti-oligomer agents against a-synuclein and 2N4R tau. Bioorg Med Chem. 2024 Dec 15; 116:117990.
    View in: PubMed
    Score: 0.007
  89. Associations of semaglutide with first-time diagnosis of Alzheimer's disease in patients with type 2 diabetes: Target trial emulation using nationwide real-world data in the US. Alzheimers Dement. 2024 Dec; 20(12):8661-8672.
    View in: PubMed
    Score: 0.007
  90. Evaluation of Alpha-Synuclein and Tau Antiaggregation Activity of Urea and Thiourea-Based Small Molecules for Neurodegenerative Disease Therapeutics. ACS Chem Neurosci. 2024 11 06; 15(21):3915-3931.
    View in: PubMed
    Score: 0.007
  91. Sensory Dysfunction, Microbial Infections, and Host Responses in Alzheimer's Disease. J Infect Dis. 2024 Sep 10; 230(Supplement_2):S150-S164.
    View in: PubMed
    Score: 0.007
  92. Microglial modulation as a therapeutic strategy in Alzheimer's disease: Focus on microglial preconditioning approaches. J Cell Mol Med. 2024 Aug; 28(15):e18554.
    View in: PubMed
    Score: 0.007
  93. Donanemab, another anti-Alzheimer's drug with risk and uncertain benefit. Ageing Res Rev. 2024 Aug; 99:102348.
    View in: PubMed
    Score: 0.007
  94. Label-Free In Situ Chemical Characterization of Amyloid Plaques in Human Brain Tissues. ACS Chem Neurosci. 2024 04 03; 15(7):1469-1483.
    View in: PubMed
    Score: 0.007
  95. Sex-Specific Early Retinal Dysfunction in Mutant TDP-43 Transgenic Mice. J Alzheimers Dis. 2024; 97(2):927-937.
    View in: PubMed
    Score: 0.007
  96. Meta-Analysis in Transgenic Alzheimer's Disease Mouse Models Reveals Opposite Brain Network Effects of Amyloid-ß and Phosphorylated Tau Proteins. J Alzheimers Dis. 2024; 99(2):595-607.
    View in: PubMed
    Score: 0.007
  97. Fueling Alzheimer's Disease: Where Does Immunometabolism Stand? J Alzheimers Dis. 2024; 100(s1):S363-S385.
    View in: PubMed
    Score: 0.007
  98. Endocrine Dyscrasia in the Etiology and Therapy of Alzheimer's Disease. J Alzheimers Dis. 2024; 101(3):705-713.
    View in: PubMed
    Score: 0.007
  99. Global Challenges After a Global Challenge: Lessons Learned from the COVID-19 Pandemic. Adv Exp Med Biol. 2024; 1457:1-31.
    View in: PubMed
    Score: 0.007
  100. Prion disease and Alzheimer's disease: pathogenic overlap. Acta Neurobiol Exp (Wars). 2004; 64(1):11-7.
    View in: PubMed
    Score: 0.007
  101. Revision of Alzheimer's diagnostic criteria or relocation of the Potemkin village. Ageing Res Rev. 2024 01; 93:102173.
    View in: PubMed
    Score: 0.007
  102. Evaluation of N- and O-Linked Indole Triazines for a Dual Effect on a-Synuclein and Tau Aggregation. ACS Chem Neurosci. 2023 11 01; 14(21):3913-3927.
    View in: PubMed
    Score: 0.007
  103. Applying an evolutionary mismatch framework to understand disease susceptibility. PLoS Biol. 2023 09; 21(9):e3002311.
    View in: PubMed
    Score: 0.007
  104. Oxidative damage in the olfactory system in Alzheimer's disease. Acta Neuropathol. 2003 Dec; 106(6):552-6.
    View in: PubMed
    Score: 0.007
  105. Passive Alzheimer's immunotherapy: A promising or uncertain option? Ageing Res Rev. 2023 09; 90:101996.
    View in: PubMed
    Score: 0.007
  106. Human subsistence and signatures of selection on chemosensory genes. Commun Biol. 2023 07 03; 6(1):683.
    View in: PubMed
    Score: 0.007
  107. Establishment of a consensus protocol to explore the brain pathobiome in patients with mild cognitive impairment and Alzheimer's disease: Research outline and call for collaboration. Alzheimers Dement. 2023 11; 19(11):5209-5231.
    View in: PubMed
    Score: 0.007
  108. Microtubule reduction in Alzheimer's disease and aging is independent of tau filament formation. Am J Pathol. 2003 May; 162(5):1623-7.
    View in: PubMed
    Score: 0.006
  109. Damaged mitochondria coincide with presynaptic vesicle loss and abnormalities in alzheimer's disease brain. Acta Neuropathol Commun. 2023 03 31; 11(1):54.
    View in: PubMed
    Score: 0.006
  110. Circulating long non-coding RNAs as novel diagnostic biomarkers for Alzheimer's disease (AD): A systematic review and meta-analysis. PLoS One. 2023; 18(3):e0281784.
    View in: PubMed
    Score: 0.006
  111. Adventiously-bound redox active iron and copper are at the center of oxidative damage in Alzheimer disease. Biometals. 2003 Mar; 16(1):77-81.
    View in: PubMed
    Score: 0.006
  112. The Anti-Amyloid Monoclonal Antibody Lecanemab: 16 Cautionary Notes. J Alzheimers Dis. 2023; 94(2):497-507.
    View in: PubMed
    Score: 0.006
  113. Association of COVID-19 with Risk and Progression of Alzheimer's Disease: Non-Overlapping Two-Sample Mendelian Randomization Analysis of 2.6 Million Subjects. J Alzheimers Dis. 2023; 96(4):1711-1720.
    View in: PubMed
    Score: 0.006
  114. Neuronal RNA oxidation is a prominent feature of dementia with Lewy bodies. Neuroreport. 2002 Nov 15; 13(16):2035-9.
    View in: PubMed
    Score: 0.006
  115. The International Natural Product Sciences Taskforce (INPST) and the power of Twitter networking exemplified through #INPST hashtag analysis. Phytomedicine. 2023 Jan; 108:154520.
    View in: PubMed
    Score: 0.006
  116. Hyperphosphorylated Tau Relates to Improved Cognitive Performance and Reduced Hippocampal Excitability in the Young rTg4510 Mouse Model of Tauopathy. J Alzheimers Dis. 2022; 87(2):529-543.
    View in: PubMed
    Score: 0.006
  117. Making the Case for Accelerated Withdrawal of Aducanumab. J Alzheimers Dis. 2022; 87(3):1003-1007.
    View in: PubMed
    Score: 0.006
  118. Immune modulations and immunotherapies for Alzheimer's disease: a comprehensive review. Rev Neurosci. 2022 06 27; 33(4):365-381.
    View in: PubMed
    Score: 0.006
  119. The Amyloid-ß Pathway in Alzheimer's Disease. Mol Psychiatry. 2021 10; 26(10):5481-5503.
    View in: PubMed
    Score: 0.006
  120. Challenges and Strategies of Successful Mentoring: The Perspective of LEADS Scholars and Mentors from Minority Serving Institutions. Int J Environ Res Public Health. 2021 06 07; 18(11).
    View in: PubMed
    Score: 0.006
  121. Omics sciences for systems biology in Alzheimer's disease: State-of-the-art of the evidence. Ageing Res Rev. 2021 08; 69:101346.
    View in: PubMed
    Score: 0.006
  122. Molecular Processing of Tau Protein in Progressive Supranuclear Palsy: Neuronal and Glial Degeneration. J Alzheimers Dis. 2021; 79(4):1517-1531.
    View in: PubMed
    Score: 0.006
  123. Decreased salivary lactoferrin levels are specific to Alzheimer's disease. EBioMedicine. 2020 Jul; 57:102834.
    View in: PubMed
    Score: 0.005
  124. Chronic traumatic encephalopathy neuropathology might not be inexorably progressive or unique to repetitive neurotrauma. Brain. 2019 Dec 01; 142(12):3672-3693.
    View in: PubMed
    Score: 0.005
  125. Genomic Evidence for Local Adaptation of Hunter-Gatherers to the African Rainforest. Curr Biol. 2019 09 09; 29(17):2926-2935.e4.
    View in: PubMed
    Score: 0.005
  126. Natural selection contributed to immunological differences between hunter-gatherers and agriculturalists. Nat Ecol Evol. 2019 08; 3(8):1253-1264.
    View in: PubMed
    Score: 0.005
  127. Impact of DNA degradation on massively parallel sequencing-based autosomal STR, iiSNP, and mitochondrial DNA typing systems. Int J Legal Med. 2019 Sep; 133(5):1369-1380.
    View in: PubMed
    Score: 0.005
  128. The sterol regulatory element-binding protein 2 is dysregulated by tau alterations in Alzheimer disease. Brain Pathol. 2019 07; 29(4):530-543.
    View in: PubMed
    Score: 0.005
  129. No Evidence of Increased Chronic Traumatic Encephalopathy Pathology or Neurodegenerative Proteinopathy in Former Military Service Members: A Preliminary Study. J Alzheimers Dis. 2019; 67(4):1277-1289.
    View in: PubMed
    Score: 0.005
  130. Lithium as a Treatment for Alzheimer's Disease: The Systems Pharmacology Perspective. J Alzheimers Dis. 2019; 69(3):615-629.
    View in: PubMed
    Score: 0.005
  131. Phospho-Tau Protein Expression in the Cell Cycle of SH-SY5Y Neuroblastoma Cells: A Morphological Study. J Alzheimers Dis. 2019; 71(2):631-645.
    View in: PubMed
    Score: 0.005
  132. Neuropathology in Consecutive Forensic Consultation Cases with a History of Remote Traumatic Brain Injury. J Alzheimers Dis. 2019; 72(3):683-691.
    View in: PubMed
    Score: 0.005
  133. Polygenic adaptation and convergent evolution on growth and cardiac genetic pathways in African and Asian rainforest hunter-gatherers. Proc Natl Acad Sci U S A. 2018 11 27; 115(48):E11256-E11263.
    View in: PubMed
    Score: 0.005
  134. Diminished O-GlcNAcylation in Alzheimer's disease is strongly correlated with mitochondrial anomalies. Biochim Biophys Acta Mol Basis Dis. 2019 08 01; 1865(8):2048-2059.
    View in: PubMed
    Score: 0.005
  135. From Oxidative Stress to Ageing via Lifestyle, Nutraceuticals, Polypharmacy, and Neuropsychological Factors. Oxid Med Cell Longev. 2018; 2018:6352689.
    View in: PubMed
    Score: 0.005
  136. Differences in structure and function between human and murine tau. Biochim Biophys Acta Mol Basis Dis. 2019 08 01; 1865(8):2024-2030.
    View in: PubMed
    Score: 0.005
  137. Discourses of disease, discourses of disadvantage: a critical analysis of National Pandemic Influenza Preparedness Plans. Soc Sci Med. 2008 Oct; 67(7):1133-42.
    View in: PubMed
    Score: 0.005
  138. Nanoscale synchrotron X-ray speciation of iron and calcium compounds in amyloid plaque cores from Alzheimer's disease subjects. Nanoscale. 2018 Jul 05; 10(25):11782-11796.
    View in: PubMed
    Score: 0.005
  139. Transplantation of Human Chorion-Derived Cholinergic Progenitor Cells: a Novel Treatment for Neurological Disorders. Mol Neurobiol. 2019 Jan; 56(1):307-318.
    View in: PubMed
    Score: 0.005
  140. The demographic history and mutational load of African hunter-gatherers and farmers. Nat Ecol Evol. 2018 04; 2(4):721-730.
    View in: PubMed
    Score: 0.005
  141. Precision pharmacology for Alzheimer's disease. Pharmacol Res. 2018 04; 130:331-365.
    View in: PubMed
    Score: 0.005
  142. Expression of growth hormone gene in the baboon eye. Exp Eye Res. 2018 04; 169:157-169.
    View in: PubMed
    Score: 0.005
  143. Putative Gonadotropin-Releasing Hormone Agonist Therapy and Dementia: An Application of Medicare Hospitalization Claims Data. J Alzheimers Dis. 2018; 63(4):1269-1277.
    View in: PubMed
    Score: 0.004
  144. An Inducible Alpha-Synuclein Expressing Neuronal Cell Line Model for Parkinson's Disease1. J Alzheimers Dis. 2018; 66(2):453-460.
    View in: PubMed
    Score: 0.004
  145. Transposable elements are the primary source of novelty in primate gene regulation. Genome Res. 2017 10; 27(10):1623-1633.
    View in: PubMed
    Score: 0.004
  146. Social justice and disadvantaged groups. Hastings Cent Rep. 2007 Jul-Aug; 37(4):32-9.
    View in: PubMed
    Score: 0.004
  147. An evolutionary medicine perspective on Neandertal extinction. J Hum Evol. 2017 07; 108:62-71.
    View in: PubMed
    Score: 0.004
  148. Dispersals and genetic adaptation of Bantu-speaking populations in Africa and North America. Science. 2017 05 05; 356(6337):543-546.
    View in: PubMed
    Score: 0.004
  149. Selenoprotein S Reduces Endoplasmic Reticulum Stress-Induced Phosphorylation of Tau: Potential Role in Selenate Mitigation of Tau Pathology. J Alzheimers Dis. 2017; 55(2):749-762.
    View in: PubMed
    Score: 0.004
  150. Anthocyanins: Multi-Target Agents for Prevention and Therapy of Chronic Diseases. Curr Pharm Des. 2017; 23(41):6321-6346.
    View in: PubMed
    Score: 0.004
  151. Divergent Ah Receptor Ligand Selectivity during Hominin Evolution. Mol Biol Evol. 2016 10; 33(10):2648-58.
    View in: PubMed
    Score: 0.004
  152. Mitochondrial traffic jams in Alzheimer's disease - pinpointing the roadblocks. Biochim Biophys Acta. 2016 10; 1862(10):1909-17.
    View in: PubMed
    Score: 0.004
  153. Beta-amyloid 1-42 monomers, but not oligomers, produce PHF-like conformation of Tau protein. Aging Cell. 2016 10; 15(5):914-23.
    View in: PubMed
    Score: 0.004
  154. Alzheimer disease research in the 21st century: past and current failures, new perspectives and funding priorities. Oncotarget. 2016 Jun 28; 7(26):38999-39016.
    View in: PubMed
    Score: 0.004
  155. 1,3-propanediol binds deep inside the channel to inhibit water permeation through aquaporins. Protein Sci. 2016 Feb; 25(2):433-41.
    View in: PubMed
    Score: 0.004
  156. Laser-Induced In-Source Decay Applied to the Determination of Amyloid-Beta in Alzheimer's Brains. ACS Chem Neurosci. 2016 Mar 16; 7(3):261-8.
    View in: PubMed
    Score: 0.004
  157. Euarchontan Opsin Variation Brings New Focus to Primate Origins. Mol Biol Evol. 2016 Apr; 33(4):1029-41.
    View in: PubMed
    Score: 0.004
  158. Microbes and Alzheimer's Disease. J Alzheimers Dis. 2016; 51(4):979-84.
    View in: PubMed
    Score: 0.004
  159. The epigenomic landscape of African rainforest hunter-gatherers and farmers. Nat Commun. 2015 Nov 30; 6:10047.
    View in: PubMed
    Score: 0.004
  160. Elephantid Genomes Reveal the Molecular Bases of Woolly Mammoth Adaptations to the Arctic. Cell Rep. 2015 Jul 14; 12(2):217-28.
    View in: PubMed
    Score: 0.004
  161. Chronic effects of mild neurotrauma: putting the cart before the horse? J Neuropathol Exp Neurol. 2015 Jun; 74(6):493-9.
    View in: PubMed
    Score: 0.004
  162. Cerebrovascular and mitochondrial abnormalities in Alzheimer's disease: a brief overview. J Neural Transm (Vienna). 2016 Feb; 123(2):107-11.
    View in: PubMed
    Score: 0.004
  163. A clinical study of lupron depot in the treatment of women with Alzheimer's disease: preservation of cognitive function in patients taking an acetylcholinesterase inhibitor and treated with high dose lupron over 48 weeks. J Alzheimers Dis. 2015; 44(2):549-60.
    View in: PubMed
    Score: 0.004
  164. From Neurodegeneration to Brain Health: An Integrated Approach. J Alzheimers Dis. 2015; 46(1):271-83.
    View in: PubMed
    Score: 0.004
  165. Khoisan hunter-gatherers have been the largest population throughout most of modern-human demographic history. Nat Commun. 2014 Dec 04; 5:5692.
    View in: PubMed
    Score: 0.004
  166. Natural selection for the Duffy-null allele in the recently admixed people of Madagascar. Proc Biol Sci. 2014 Aug 22; 281(1789):20140930.
    View in: PubMed
    Score: 0.004
  167. Comparative metabolomics in primates reveals the effects of diet and gene regulatory variation on metabolic divergence. Sci Rep. 2014 Jul 28; 4:5809.
    View in: PubMed
    Score: 0.004
  168. Accumulation of intraneuronal amyloid-ß is common in normal brain. Curr Alzheimer Res. 2014 May; 11(4):317-24.
    View in: PubMed
    Score: 0.003
  169. Oxidative stress and mitochondrial dysfunction in Alzheimer's disease. Biochim Biophys Acta. 2014 Aug; 1842(8):1240-7.
    View in: PubMed
    Score: 0.003
  170. Antimicrobial peptide ß-defensin-1 expression is upregulated in Alzheimer's brain. J Neuroinflammation. 2013 Oct 18; 10:127.
    View in: PubMed
    Score: 0.003
  171. Is exercise-in-a-bottle likely to proffer new insights into Alzheimer's disease? J Neurochem. 2013 Oct; 127(1):4-6.
    View in: PubMed
    Score: 0.003
  172. The structures of the E22? mutant-type amyloid-ß alloforms and the impact of E22? mutation on the structures of the wild-type amyloid-ß alloforms. ACS Chem Neurosci. 2013 Feb 20; 4(2):310-20.
    View in: PubMed
    Score: 0.003
  173. ASPM and the evolution of cerebral cortical size in a community of New World monkeys. PLoS One. 2012; 7(9):e44928.
    View in: PubMed
    Score: 0.003
  174. Regulatory element copy number differences shape primate expression profiles. Proc Natl Acad Sci U S A. 2012 Jul 31; 109(31):12656-61.
    View in: PubMed
    Score: 0.003
  175. Do ß-defensins and other antimicrobial peptides play a role in neuroimmune function and neurodegeneration? ScientificWorldJournal. 2012; 2012:905785.
    View in: PubMed
    Score: 0.003
  176. The role of iron as a mediator of oxidative stress in Alzheimer disease. Biofactors. 2012 Mar-Apr; 38(2):133-8.
    View in: PubMed
    Score: 0.003
  177. Amyloid-ß peptide structure in aqueous solution varies with fragment size. J Chem Phys. 2011 Nov 28; 135(20):205101.
    View in: PubMed
    Score: 0.003
  178. Mark A. Smith, 1965-2010: consummate student of pathogenesis. Int J Clin Exp Pathol. 2011; 4(7):731-2.
    View in: PubMed
    Score: 0.003
  179. A novel origin for granulovacuolar degeneration in aging and Alzheimer's disease: parallels to stress granules. Lab Invest. 2011 Dec; 91(12):1777-86.
    View in: PubMed
    Score: 0.003
  180. The cell cycle regulator phosphorylated retinoblastoma protein is associated with tau pathology in several tauopathies. J Neuropathol Exp Neurol. 2011 Jul; 70(7):578-87.
    View in: PubMed
    Score: 0.003
  181. DLP1-dependent mitochondrial fragmentation mediates 1-methyl-4-phenylpyridinium toxicity in neurons: implications for Parkinson's disease. Aging Cell. 2011 Oct; 10(5):807-23.
    View in: PubMed
    Score: 0.003
  182. Modeling cholesterol metabolism by gene expression profiling in the hippocampus. Mol Biosyst. 2011 Jun; 7(6):1891-901.
    View in: PubMed
    Score: 0.003
  183. Widespread distribution of reticulon-3 in various neurodegenerative diseases. Neuropathology. 2010 Dec; 30(6):574-9.
    View in: PubMed
    Score: 0.003
  184. CD3 in Lewy pathology: does the abnormal recall of neurodevelopmental processes underlie Parkinson's disease. J Neural Transm (Vienna). 2011 Jan; 118(1):23-6.
    View in: PubMed
    Score: 0.003
  185. Evolutionary adaptations to dietary changes. Annu Rev Nutr. 2010 Aug 21; 30:291-314.
    View in: PubMed
    Score: 0.003
  186. Variably protease-sensitive prionopathy: a new sporadic disease of the prion protein. Ann Neurol. 2010 Aug; 68(2):162-72.
    View in: PubMed
    Score: 0.003
  187. Paraffin-embedded tissue (PET) blot method: application to Alzheimer disease. J Neurosci Methods. 2010 Jul 15; 190(2):244-7.
    View in: PubMed
    Score: 0.003
  188. Causes versus effects: the increasing complexities of Alzheimer's disease pathogenesis. Expert Rev Neurother. 2010 May; 10(5):683-91.
    View in: PubMed
    Score: 0.003
  189. Indoleamine 2,3-dioxygenase and 3-hydroxykynurenine modifications are found in the neuropathology of Alzheimer's disease. Redox Rep. 2010; 15(4):161-8.
    View in: PubMed
    Score: 0.003
  190. Evidence for the progression through S-phase in the ectopic cell cycle re-entry of neurons in Alzheimer disease. Aging (Albany NY). 2009 Apr; 1(4):382-8.
    View in: PubMed
    Score: 0.002
  191. The neuronal expression of MYC causes a neurodegenerative phenotype in a novel transgenic mouse. Am J Pathol. 2009 Mar; 174(3):891-7.
    View in: PubMed
    Score: 0.002
  192. Reexamining Alzheimer's disease: evidence for a protective role for amyloid-beta protein precursor and amyloid-beta. J Alzheimers Dis. 2009; 18(2):447-52.
    View in: PubMed
    Score: 0.002
  193. Cell cycle re-entry mediated neurodegeneration and its treatment role in the pathogenesis of Alzheimer's disease. Neurochem Int. 2009 Feb; 54(2):84-8.
    View in: PubMed
    Score: 0.002
  194. Phosphorylated tau: toxic, protective, or none of the above. J Alzheimers Dis. 2008 Aug; 14(4):377-83.
    View in: PubMed
    Score: 0.002
  195. Alzheimer disease pathology as a host response. J Neuropathol Exp Neurol. 2008 Jun; 67(6):523-31.
    View in: PubMed
    Score: 0.002
  196. Antigen-antibody dissociation in Alzheimer disease: a novel approach to diagnosis. J Neurochem. 2008 Aug; 106(3):1350-6.
    View in: PubMed
    Score: 0.002
  197. On the analysis of copy-number variations in genome-wide association studies: a translation of the family-based association test. Genet Epidemiol. 2008 Apr; 32(3):273-84.
    View in: PubMed
    Score: 0.002
  198. Current approaches in the treatment of Alzheimer's disease. Biomed Pharmacother. 2008 Apr-May; 62(4):199-207.
    View in: PubMed
    Score: 0.002
  199. Redox active iron accumulation in aceruloplasminemia. Neuropathology. 2008 Oct; 28(5):466-71.
    View in: PubMed
    Score: 0.002
  200. Analysis of copy number variation in the rhesus macaque genome identifies candidate loci for evolutionary and human disease studies. Hum Mol Genet. 2008 Apr 15; 17(8):1127-36.
    View in: PubMed
    Score: 0.002
  201. The role of novel chitin-like polysaccharides in Alzheimer disease. Neurotox Res. 2007 Dec; 12(4):269-74.
    View in: PubMed
    Score: 0.002
  202. Iron: the Redox-active center of oxidative stress in Alzheimer disease. Neurochem Res. 2007 Oct; 32(10):1640-5.
    View in: PubMed
    Score: 0.002
  203. Neuropathology and treatment of Alzheimer disease: did we lose the forest for the trees? Expert Rev Neurother. 2007 May; 7(5):473-85.
    View in: PubMed
    Score: 0.002
  204. Identification of the imprinted KLF14 transcription factor undergoing human-specific accelerated evolution. PLoS Genet. 2007 May 04; 3(5):e65.
    View in: PubMed
    Score: 0.002
  205. Amyloid-beta in Alzheimer disease: the null versus the alternate hypotheses. J Pharmacol Exp Ther. 2007 Jun; 321(3):823-9.
    View in: PubMed
    Score: 0.002
  206. Cerebrotendinous xanthomatosis: case report with evidence of oxidative stress. Redox Rep. 2007; 12(3):119-24.
    View in: PubMed
    Score: 0.002
  207. Global variation in copy number in the human genome. Nature. 2006 Nov 23; 444(7118):444-54.
    View in: PubMed
    Score: 0.002
  208. Accurate and reliable high-throughput detection of copy number variation in the human genome. Genome Res. 2006 Dec; 16(12):1566-74.
    View in: PubMed
    Score: 0.002
  209. LRRK2 protein is a component of Lewy bodies. Ann Neurol. 2006 Nov; 60(5):617-618.
    View in: PubMed
    Score: 0.002
  210. Increased expression of p130 in Alzheimer disease. Neurochem Res. 2007 Apr-May; 32(4-5):639-44.
    View in: PubMed
    Score: 0.002
  211. Malignant glioma progression and nitric oxide. Neurochem Int. 2006 Dec; 49(8):764-8.
    View in: PubMed
    Score: 0.002
  212. Involvement of oxidative stress in Alzheimer disease. J Neuropathol Exp Neurol. 2006 Jul; 65(7):631-41.
    View in: PubMed
    Score: 0.002
  213. Copy number variation: new insights in genome diversity. Genome Res. 2006 Aug; 16(8):949-61.
    View in: PubMed
    Score: 0.002
  214. Neuropathology in Alzheimer's disease: awaking from a hundred-year-old dream. Sci Aging Knowledge Environ. 2006 May 03; 2006(8):pe10.
    View in: PubMed
    Score: 0.002
  215. Neuropathology of Alzheimer disease: pathognomonic but not pathogenic. Acta Neuropathol. 2006 Jun; 111(6):503-9.
    View in: PubMed
    Score: 0.002
  216. Antioxidant protection and neurodegenerative disease: the role of amyloid-beta and tau. Am J Alzheimers Dis Other Demen. 2006 Mar-Apr; 21(2):126-30.
    View in: PubMed
    Score: 0.002
  217. Chitin-like polysaccharides in Alzheimer's disease brains. Curr Alzheimer Res. 2005 Oct; 2(4):419-23.
    View in: PubMed
    Score: 0.002
  218. Amyloid-beta in Alzheimer's disease: the horse or the cart? Pathogenic or protective? Int J Exp Pathol. 2005 Jun; 86(3):133-8.
    View in: PubMed
    Score: 0.002
  219. Contribution of redox-active iron and copper to oxidative damage in Alzheimer disease. Ageing Res Rev. 2004 Jul; 3(3):319-26.
    View in: PubMed
    Score: 0.002
  220. Cerebral amyloid angiopathy: major contributor or decorative response to Alzheimer's disease pathogenesis. Neurobiol Aging. 2004 May-Jun; 25(5):599-602; discussion 603-4.
    View in: PubMed
    Score: 0.002
  221. Elevated expression of a regulator of the G2/M phase of the cell cycle, neuronal CIP-1-associated regulator of cyclin B, in Alzheimer's disease. J Neurosci Res. 2004 Mar 01; 75(5):698-703.
    View in: PubMed
    Score: 0.002
  222. Role of mitochondrial dysfunction in Alzheimer's disease. J Neurosci Res. 2002 Nov 01; 70(3):357-60.
    View in: PubMed
    Score: 0.002
  223. Oxidative damage to nucleic acids in human prion disease. Neurobiol Dis. 2002 Apr; 9(3):275-81.
    View in: PubMed
    Score: 0.002
  224. Systemic increase of oxidative nucleic acid damage in Parkinson's disease and multiple system atrophy. Neurobiol Dis. 2002 Mar; 9(2):244-8.
    View in: PubMed
    Score: 0.001
  225. Hydroxynonenal adducts indicate a role for lipid peroxidation in neocortical and brainstem Lewy bodies in humans. Neurosci Lett. 2002 Feb 08; 319(1):25-8.
    View in: PubMed
    Score: 0.001
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.